[{"ID":"35384_75-2021_NCT00865371","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease.\n\nAccording to the INCLUSION CRITERIA:\n\n* Is the individual a healthy, normal adult man who volunteers to participate? No, the patient has Parkinson's disease.\n\nTherefore, the patient is NOT eligible for the clinical trial.","PROBA":0.9023621241},{"ID":"28014_40-2022_NCT04053699","TOPIC_YEAR":2022,"RESPONSE":"# A: eligible","PROBA":0.6664453794},{"ID":"30398_65-2021_NCT00125437","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 25-year-old man with type 1 diabetes and cardiomyopathy.\n\nINCLUSION CRITERIA:\n\n* New York Heart Association (NYHA) Functional class \u2162 or \u2163: Yes, the patient is in NYHA class \u2161.\n* Left Ventricular Ejection Fraction (LVEF) <35%: Yes, the patient's LVEF is <35%.\n* Nonischemic cardiomyopathy: Yes, the patient has nonischemic cardiomyopathy.\n* Preserved renal function: Cr \u22642.5 mg\/dL in males; Cr \u22642.0mg\/dL in females: Yes, the patient's creatinine level is within normal limits.\n\nThe patient meets all the inclusion criteria and none of the exclusion criteria, so the patient is eligible for the clinical trial.","PROBA":0.9488503783},{"ID":"25078_53-2021_NCT01402115","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 34-year-old woman from Jordan who comes to clinic with some general and non-specific bones and joints pain.\n\nBased on the patient's age (34), she is within the inclusion criteria age range of 40-70 years.\n\nThe patient's BMI is 23, which is within the normal weight range and not excluded by the exclusion criteria BMI >30 kg\/m2.\n\nThe patient is not taking any medications that are excluded by the exclusion criteria (estrogens, corticosteroids, or bisphosphonates).\n\nThe patient does not have any significant illness affecting bone metabolism, as the only symptom mentioned is general and non-specific bones and joints pain.\n\nTherefore, the patient is eligible for the clinical trial.\n\nA: eligible","PROBA":0.9077417902},{"ID":"5309_12-2021_NCT01621971","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 34-year-old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation.\n\nINCLUSION CRITERIA:\n\n* patients undergoing mitral valve surgery for chronic mitral regurgitation\n\nThe patient meets this criterion.\n\n* estimated pulmonary hypertension (systolic PAP > 50 mmHg estimated by the velocity of tricuspid valve regurgitation in preoperative transthoracic echocardiography)\n\nThe patient's echocardiogram shows a systolic pulmonary artery pressure of 55 mmHg, which meets this criterion.\n\nThe patient is eligible for the clinical trial.\n\nA: eligible","PROBA":0.9388127386},{"ID":"18652_27-2022_NCT00005657","TOPIC_YEAR":2022,"RESPONSE":"The patient is a 31-year-old woman with a diagnosis of Lyme disease.\n\nThe clinical trial is for Genetics of Hepatitis C Virus Infection.\n\nLyme disease and Hepatitis C Virus Infection are two completely different conditions.\n\nTherefore, the patient is not eligible for the clinical trial.\n\nC: irrelevant","PROBA":0.912032472},{"ID":"35639_75-2021_NCT03301272","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 55 years old, which is within the age range of 45-80 years old specified in the inclusion criteria. Therefore, the patient meets the age requirement.\n\n#2: Diagnosis\nThe patient has been diagnosed with Parkinson's disease, which meets the inclusion criteria of having Parkinson's disease.\n\n#3: Rest tremor\nThe patient has a rest tremor of at least 3 cm amplitude, which meets the inclusion criteria.\n\n#4: Medication history\nThe patient has a history of being refractory to at least 2 categories of medications typically used as anti-parkinsonian agents, including levodopa formulations, dopamine agonists, amantadine, and anticholinergics. This meets the inclusion criteria.\n\n#5: Ability to make changes to medications\nThe patient must be able to make no changes to their anti-parkinsonian medications for 150 days (study duration). The patient's treating physician must confirm in writing prior to participating that the patient is able to do so. This is not explicitly stated in the patient note, but it is implied that the patient is able to make no changes to their medications since they are being considered for the clinical trial.\n\n#6: Allergy\nThere is no mention of any allergies in the patient note.\n\n#7: Cognitive function\nThere is no mention of cognitive function in the patient note.\n\n#8: Muscle weakness\nThere is no mention of muscle weakness in the patient note.\n\n#9: Pregnancy\nThere is no mention of pregnancy in the patient note.\n\n#10: Infection\nThere is no mention of infection in the patient note.\n\nBased on the patient note, the patient meets all the inclusion criteria and none of the exclusion criteria, so the patient is eligible for the clinical trial.","PROBA":0.9352806539},{"ID":"35828_75-2021_NCT04821830","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man with a recent diagnosis of Parkinson's disease, which meets the inclusion criterion of the clinical trial.\n\nThe patient's disease is classified as mild to moderate (Hoehn-Yahr Stage I), which also meets the inclusion criterion.\n\nThe patient is about to start treatment with a L-Dopa preparation (Sinemet), which is an inclusion criterion.\n\nThe patient does not have any exclusion criteria, such as the presence of other neurological diseases, depression, or cognitive impairment.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9231597767},{"ID":"35538_75-2021_NCT02370134","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man with Parkinson's disease, which meets the inclusion criteria of the clinical trial.\n\nThe patient has a mild form of the disease, as indicated by the Hoehn-Yahr Stage I classification.\n\nThe patient is experiencing rest tremor, which is one of the predominant features of Parkinson's disease and is intractable to medical treatment, meeting the inclusion criteria.\n\nThe patient is alert and cooperative, which suggests that they are able to provide informed consent, meeting the inclusion criteria.\n\nThe patient does not have any of the exclusion criteria, such as a history of cardiac arrhythmia, renal failure, hepatic failure, pregnancy, seizure, or implanted devices, that would disqualify them from participating in the clinical trial.\n\nTherefore, the patient is eligible for the clinical trial.\n\nA: eligible","PROBA":0.9043894365},{"ID":"35697_75-2021_NCT03808675","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.7215129859},{"ID":"35511_75-2021_NCT02037451","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man with a clinical diagnosis of Parkinson's disease.\n\nYes, the patient meets the INCLUSION CRITERIA for the clinical trial.\n\nB: excluded","PROBA":0.864415278},{"ID":"14149_30-2021_NCT03097237","TOPIC_YEAR":2021,"RESPONSE":"The patient is a woman with a BMI of 31, which is within the inclusion criteria range of 27-35 kg\/m2.\n\nShe has high TSH level (13 mU\/L) and low free T4 level (0.2 ng\/dl), which indicates that she has hypothyroidism. This is within the inclusion criteria of serum thyroid stimulating hormone (TSH) \u22644.00 mIU\/L.\n\nShe is not taking any medication for her thyroid condition, which is within the inclusion criteria of not using nicotine products on a daily basis and not following any weight reduction program.\n\nShe does not have any of the exclusion criteria, such as history of stomach or gastrointestinal conditions, previous gastrointestinal surgery, or food allergies or intolerances.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9185049715},{"ID":"6765_15-2021_NCT01897623","TOPIC_YEAR":2021,"RESPONSE":"#1. Is the patient male?\nB: excluded","PROBA":0.6457154346},{"ID":"35774_75-2021_NCT04308135","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.6935252887},{"ID":"23470_33-2022_NCT03059043","TOPIC_YEAR":2022,"RESPONSE":"The patient is a 20-year-old man with myopia, which meets the inclusion criteria of the clinical trial.\n\nThe patient is cooperative with his medical appointments, which is not a criterion for the clinical trial but is a positive aspect of the patient's compliance.\n\nThe patient is working as a driver, which is not a criterion for the clinical trial but may be relevant to the patient's ability to undergo the procedure and follow-up appointments.\n\nThe patient has no preexisting ocular diseases or conditions other than myopia, which meets the exclusion criteria of the clinical trial.\n\nThe patient has no evidence of connective tissue disease or other systemic diseases that may confound the results of the study, which meets the exclusion criteria of the clinical trial.\n\nThe patient's anterior chamber depth is normal, which meets the inclusion criteria of the clinical trial.\n\nThe patient's endothelial cell density is normal, which meets the inclusion criteria of the clinical trial.\n\nThe patient's pupil diameter is normal, which meets the inclusion criteria of the clinical trial.\n\nTherefore, the patient is eligible for the clinical trial.\n\nA: eligible","PROBA":0.9276802677},{"ID":"13938_30-2021_NCT00271427","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 33-year-old woman with Hashimoto's thyroiditis.\n\nHashimoto's thyroiditis is a type of autoimmune thyroiditis, which is a type of AIT.\n\nThe patient is currently using Levothyroxine (LT4) to keep her TSH levels in the lower half of the normal range.\n\nTherefore, the patient meets the INCLUSION CRITERIA for the clinical trial, as she is a clinically approved AIT patient who is not using any medication other than LT4 to keep her TSH levels in the lower half of the normal range.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9235356081},{"ID":"5545_12-2021_NCT04527367","TOPIC_YEAR":2021,"RESPONSE":"$}}%A: eligible%]\n\nB: excluded","PROBA":0.6636054975},{"ID":"27645_40-2022_NCT01526915","TOPIC_YEAR":2022,"RESPONSE":"The patient is a 23-year-old female who has prolonged oral bleeding after a tooth extraction.\n\nINCLUSION CRITERIA:\n\n* Patient major (male or female): Eligible\n* Documented indication at the initial visit at day 0 (JO) for a maximum extraction of 3 teeth: Eligible\n* Treatment with nitrogenous or non-nitrogenous BP by intravenous injection or oral administration whichever the reason for this drug prescription: Not Applicable (the patient is not taking bisphosphonates)\n* Patient having received a previous treatment with bisphosphonates (irrespective of the duration and withdrawal date of this treatment): Not Applicable\n\nThe patient meets all the inclusion criteria and none of the exclusion criteria, so she is eligible for the clinical trial.","PROBA":0.9538539648},{"ID":"27964_40-2022_NCT03751800","TOPIC_YEAR":2022,"RESPONSE":"The patient is a 23-year-old female with heavy menstrual bleeding.\n\nINCLUSION CRITERIA:\n\n* Women in childbearing age, \u226518 years old, not intending to become pregnant during the next year.\n\nThe patient meets this criterion.\n\n* Women diagnosed with heavy menstrual bleeding or idiopathic menorrhagia according to medical criteria and based on clinical judgment.\n\nThe patient meets this criterion, as she has prolonged oral bleeding after a tooth extraction.\n\n* Women for whom the clinician decides, in agreement with the patient, to prescribe any of the available chronic hormonal treatments with the therapeutic indication of HMB in Spain (Mirena, Qlaira or Progevera).\n\nThe patient does not meet this criterion, as she has not been prescribed any chronic hormonal treatment.\n\n* Women capable of reading and writing.\n\nThe patient meets this criterion.\n\n* Women who signed the informed consent.\n\nThe patient meets this criterion.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9592702687},{"ID":"33481_71-2021_NCT00909766","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.6726798867},{"ID":"6892_15-2021_NCT02972671","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient male or female?\n\nB: excluded","PROBA":0.722803265},{"ID":"6630_15-2021_NCT00630513","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient an adult (> 18 years)?\nYes, the patient is an adult.\n\n#2: Does the patient require surgical intervention within 24 hours of diagnosis?\nYes, the patient requires surgical intervention for the pancreatic adenocarcinoma.\n\n#3: Does the patient have a community-acquired IAI of mild to moderate severity?\nYes, the patient has a community-acquired IAI of mild to moderate severity (pancreatic adenocarcinoma).\n\n#4: Is the patient excluded for any other reason?\nNo, the patient is not excluded for any other reason.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9178505653},{"ID":"27599_40-2022_NCT01190150","TOPIC_YEAR":2022,"RESPONSE":"#1: Is the patient generally healthy?\nYes, the patient is generally healthy.\n\n#2: Does the patient have a history of at least 1 year of cyclic heavy menstrual bleeding?\nYes, the patient has a history of heavy menstrual bleeding.\n\n#3: Does the patient meet the criteria for HMB based on laboratory and physical findings?\nYes, the patient meets the criteria for HMB based on laboratory and physical findings.\n\n#4: Is the patient sexually inactive or using an acceptable birth control method?\nYes, the patient is sexually inactive.\n\n#5: Does the patient have any exclusion criteria?\nNo, the patient does not have any exclusion criteria.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9268460327},{"ID":"14016_30-2021_NCT01420419","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 33-year-old woman who is breastfeeding and experiencing nipple pain.\n\nINCLUSION CRITERIA:\n\n* Maternal complaint of nipple pain with any sign of nipple trauma to one or both nipples\n\nThe patient meets this criterion.\n\n* Infant delivered at, or greater than 37 weeks gestation\n\nThe patient's infant was delivered at 37 weeks gestation, so this criterion is met.\n\n* Singleton birth\n\nThe patient had a singleton birth, so this criterion is met.\n\n* Speaks and understands English\n\nThe patient speaks and understands English, so this criterion is met.\n\n* Access to telephone\n\nThe patient has access to a telephone, so this criterion is met.\n\nThe patient meets all of the inclusion criteria, so she is eligible for the clinical trial.\n\nC: irrelevant","PROBA":0.9466540331},{"ID":"35823_75-2021_NCT04796246","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man with Parkinson's disease, which meets the inclusion criteria of the clinical trial.\n\nThe patient is classified as Hoehn-Yahr Stage I, which is within the range of I-III on the Hoehn & Yahr motor staging scale, which also meets the inclusion criteria.\n\nThe patient is over 18 years old and a resident of the city of Porto Alegre\/RS, which also meets the inclusion criteria.\n\nThe patient has signed an informed consent form, which is a requirement for participation in the clinical trial.\n\nTherefore, the patient is eligible for the clinical trial.\n\nA: eligible","PROBA":0.9171581065},{"ID":"27622_40-2022_NCT01384331","TOPIC_YEAR":2022,"RESPONSE":"#1: Age\nThe patient is 23 years old, which is within the age range of 18-45 years for the clinical trial. Therefore, the patient meets the age criterion.\n\n#2: Use of Implanon\nThe patient is an Implanon user, which meets the inclusion criterion of using the subdermal progestogen-only contraceptive implant.\n\n#3: Frequent or Prolonged Bleeding\nThe patient experiences prolonged oral bleeding after a tooth extraction, which meets the inclusion criterion of frequent or prolonged bleeding.\n\n#4: Willingness to Keep a Menstrual Diary\nThe patient is willing to keep a daily menstrual diary, which meets the inclusion criterion.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9154047452},{"ID":"5561_12-2021_NCT04766216","TOPIC_YEAR":2021,"RESPONSE":"The patient is not eligible for the clinical trial because she does not meet the inclusion criteria of being at least 18 years old and being treated with warfarin for any indication for at least 9 months prior to enrollment. The patient is only 34 years old and has not been treated with warfarin for the required minimum period.","PROBA":0.8727821437},{"ID":"30724_65-2021_NCT02230631","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 25-year-old man with type 1 diabetes...\n\nYes, the patient is eligible for the clinical trial because they meet the inclusion criteria:\n\n* Patients with T1DM (Type 1 Diabetes Mellitus) or T2DM (Type 2 Diabetes Mellitus) treated with insulin for more than 12 months\n* Patients at least 18 years of age at the time of the survey\n\nThe patient does not meet any of the exclusion criteria, so they are eligible for the clinical trial.\n\nA: eligible","PROBA":0.9325502086},{"ID":"5452_12-2021_NCT03390634","TOPIC_YEAR":2021,"RESPONSE":"34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation...\n\nC: irrelevant","PROBA":0.8693638898},{"ID":"35820_75-2021_NCT04781842","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man with Parkinson's disease, which meets the inclusion criteria.\n\nHe does not have any signs of dementia, which is not an exclusion criterion.\n\nHe does not smoke or use any illicit drugs, which is not an exclusion criterion.\n\nHe is alert and cooperative, which is not an exclusion criterion.\n\nHe has hypertension and hypercholesterolemia, which are not exclusion criteria.\n\nTherefore, the patient is eligible for the clinical trial.\n\nC: irrelevant","PROBA":0.9107767943},{"ID":"14087_30-2021_NCT02319538","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 33-year-old woman with Hashimoto's thyroiditis, which meets the inclusion criteria of the clinical trial.\n\nThe patient has already been started on Levothyroxine therapy, which is a form of thyroid hormone replacement therapy, and her symptoms have improved significantly. This meets the requirement of \"optimal thyroid substitution treatment is already provided\" in the inclusion criteria.\n\nThe patient's anti-TPO levels are high, which is a characteristic of Hashimoto's thyroiditis. This meets the requirement of \"anti-TPO>1000\" in the inclusion criteria.\n\nThe patient is not pregnant and is able to comprehend information adequately to give informed consent, which meets the requirements of the exclusion criteria.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9156661731},{"ID":"6958_15-2021_NCT03527706","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have diverticular disease?\nYes, the patient has a history of diverticulitis and a recent CT scan showing a large heterogeneous mass in the left upper abdomen, consistent with pancreatic adenocarcinoma at the head of pancreas, and splenic flecture\/pancreatic tail mass, likely diverticular abscess.\n\n#2: Is the patient scheduled for elective sigmoidectomy?\nNo, the patient is not scheduled for elective sigmoidectomy, as the clinical trial is for patients with diverticular disease, and the patient has pancreatic adenocarcinoma.\n\n#3: Is the patient >18 years old?\nYes, the patient is 70 years old.\n\n#4: Is the patient ASA 1-3?\nNo, the patient has a history of coronary artery disease, mitral valve prolapse, atrial fibrillation, hyperlipemia, hypertension, chronic kidney disease, and hypothyroidism, which would classify them as ASA 4.\n\n#5: Does the patient have informed consent?\nNo, the patient is not able to provide informed consent, as they are currently being treated for a medical condition.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9219789494},{"ID":"35733_75-2021_NCT04054960","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease.\n\nYes, the patient meets the INCLUSION CRITERIA: - Patients diagnosed with Idiopathic Parkinson's disease (IPD).\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9217021536},{"ID":"17358_36-2021_NCT04136093","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient a postmenopausal woman?\nB: eligible","PROBA":0.7784004269},{"ID":"16918_36-2021_NCT00489333","TOPIC_YEAR":2021,"RESPONSE":"The patient is obese, with a BMI of 41.54, which meets the inclusion criterion of BMI \u226530 kg\/m2.\n\nThe patient has high levels of triglycerides (150 mg\/dl), which meets the inclusion criterion of Triglycerides >150 mg\/dl.\n\nThe patient has high levels of LDL cholesterol (180 mg\/dl), which meets the inclusion criterion of LDL Cholesterol of >160 mg\/dl.\n\nThe patient has high levels of fasting blood glucose (140 mg\/dl), which meets the inclusion criterion of Fasting blood glucose >100 mg\/dl.\n\nThe patient has high blood pressure (130\/80 mm Hg), which meets the inclusion criterion of Blood pressure >130\/85 mm Hg.\n\nThe patient does not have any exclusion criteria, such as being morbidly obese (BMI >40 kg\/m2), taking any cholesterol-lowering medications, or having any systemic diseases.\n\nTherefore, the patient is eligible for the clinical trial.\n\nC: irrelevant","PROBA":0.9467463679},{"ID":"24954_53-2021_NCT00377312","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 34-year-old woman from Jordan who comes to clinic with some general and non-specific bones and joints pain.\n\nINCLUSION CRITERIA:\n\n* Healthy Caucasian, Hispanic or Asian subjects\n\nThe patient is Asian, so she meets this criterion.\n\n* Males and Females\n\nThe patient is a female, so she meets this criterion.\n\n* Non-smoker\n\nThe patient's smoking status is not specified, so she does not meet this criterion.\n\n* Ages 24 - 35 years old\n\nThe patient is 34 years old, so she meets this criterion.\n\n* Subjects will be recruited either from the employee pool of the University of Pittsburgh or the University of Pittsburgh Medical Center (UPMC), or the general population living in the vicinity.\n\nThe patient is not an employee of the University of Pittsburgh or UPMC, so she does not meet this criterion.\n\n* Participation in this study by an employee or a potential employee at the University of Pittsburgh or UPMC has no effect on their employment or potential employment.\n\nThe patient is not an employee or potential employee of the University of Pittsburgh or UPMC, so she meets this criterion.\n\n* Subjects in the study will be required to discontinue all vitamins and health food supplements two weeks prior to the study.\n\nThe patient's vitamin D level is normal, so she does not meet this criterion.\n\nBased on the provided information and the criteria for the clinical trial, the patient is not eligible for the clinical trial.","PROBA":0.9533045916},{"ID":"5483_12-2021_NCT03768115","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have dry eye symptoms that cannot be managed with currently available dry eye medication?\n\nYes, the patient has dry eye symptoms that cannot be managed with currently available dry eye medication.\n\n#2: Does the patient have a TBUT of \u226410s?\n\nNo, the patient does not have a TBUT of \u226410s.\n\n#3: Is there presence of corneal fluorescein staining?\n\nYes, there is presence of corneal fluorescein staining.\n\n#4: Is the patient's visual acuity affected by poor tear film quality?\n\nYes, the patient's visual acuity is affected by poor tear film quality.\n\n#5: Is there no contraindication for blood extraction\/plasmapheresis?\n\nYes, there is no contraindication for blood extraction\/plasmapheresis.\n\n#6: Is the patient between 21 and 99 years old?\n\nYes, the patient is between 21 and 99 years old.\n\n#7: Are there any skin lesions at the site of venepuncture in the antecubital area?\n\nNo, there are no skin lesions at the site of venepuncture in the antecubital area.\n\nBased on the above criteria, the patient is eligible for the clinical trial.","PROBA":0.960315031},{"ID":"35513_75-2021_NCT02086825","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man with Parkinson's disease.\n\nThe clinical trial is for patients with cirrhosis of the liver and acute renal failure.\n\nThe patient does not have cirrhosis of the liver or acute renal failure.\n\nTherefore, the patient is not eligible for the clinical trial.\n\nC: irrelevant","PROBA":0.9299551228},{"ID":"23291_33-2022_NCT01699607","TOPIC_YEAR":2022,"RESPONSE":"The patient is a 20-year-old man, which meets the inclusion criterion of being between 18 and 55 years old.\n\nThe patient has no current uncontrolled medical condition, such as neurological, cardiovascular, endocrine, renal, or liver pathology, which meets the inclusion criterion of having no history of a neurological or psychiatric disorder in the past 2 years.\n\nThe patient does not have any history of seizures, head injury, brain tumor, heart, liver, or kidney disease, which meets the exclusion criterion of having no history of serious medical or neurological illness.\n\nThe patient does not have any acute or unstable medical or neurological illness, which meets the exclusion criterion of having no acute or unstable medical or neurological illness.\n\nThe patient does not have any suicidal ideation or behavior, which meets the exclusion criterion of having no suicidal ideation or behavior.\n\nThe patient does not have any history of psychosis, which meets the exclusion criterion of having no history of psychosis.\n\nThe patient does not have any regular use of any psychotropic drugs, including anxiolytics and antidepressants, which meets the exclusion criterion of having no regular use of any psychotropic drugs.\n\nThe patient does not have any eating disorder, which meets the exclusion criterion of having no eating disorder.\n\nThe patient does not have any diabetes, which meets the exclusion criterion of having no diabetes.\n\nThe patient does not have any pacemaker or other ferromagnetic material in their body, which meets the exclusion criterion of having no pacemaker or other ferromagnetic material in their body.\n\nThe patient does not have any history of smoking, which meets the exclusion criterion of having no history of smoking.\n\nTherefore, the patient is eligible for the clinical trial.\n\nA: eligible","PROBA":0.9501958368},{"ID":"7102_15-2021_NCT04852406","TOPIC_YEAR":2021,"RESPONSE":"The patient is 70 years old and has a history of CAD, which meets the inclusion criterion of being over 2 weeks old.\n\nThe patient has a history of mitral valve prolapse, which is not listed as an exclusion criterion.\n\nThe patient has a history of atrial fibrillation, which is listed as an inclusion criterion.\n\nThe patient has a history of hyperlipemia, which is not listed as an exclusion criterion.\n\nThe patient has a history of hypertension, which is not listed as an exclusion criterion.\n\nThe patient has a history of chronic kidney disease, which is not listed as an exclusion criterion.\n\nThe patient has a history of hypothyroidism, which is not listed as an exclusion criterion.\n\nThe patient has a history of anemia, which is not listed as an exclusion criterion.\n\nThe patient is scheduled to undergo intra-abdominal surgery, which meets the inclusion criterion of being scheduled to undergo intra-abdominal surgery.\n\nTherefore, the patient is eligible for the clinical trial.\n\nA: eligible","PROBA":0.9396158079},{"ID":"35755_75-2021_NCT04207268","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man with Parkinson's disease, which is not one of the exclusion criteria. He has hypertension and hypercholesterolemia, which are not exclusion criteria either. He is willing to travel to the Hershey Community Garden, which is an inclusion criterion. Therefore, the patient is eligible for the clinical trial.\n\nA: eligible","PROBA":0.9104218455},{"ID":"17263_36-2021_NCT03308487","TOPIC_YEAR":2021,"RESPONSE":"The patient is a woman who is not pregnant and does not have any preexisting medical conditions. She is over 18 years old and does not meet any of the exclusion criteria. Therefore, the patient is eligible for the clinical trial.","PROBA":0.8259481391},{"ID":"35416_75-2021_NCT01161966","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man with Parkinson's disease.\n\nINCLUSION CRITERIA:\n\n* Is the individual a healthy, normal adult man or non-child bearing potential woman who volunteers to participate? - No, the patient has Parkinson's disease.\n* Is s\/he at least 18 years of age? - Yes.\n* Is his\/her BMI between 19 and 30, inclusive? - Not relevant.\n* Is s\/he considered reliable and capable of understanding his\/her responsibility and role in the study? - Not relevant.\n* Has s\/he provided written informed consent? - Not relevant.\n\nEXCLUSION CRITERIA:\n\n* Does the individual have a history of allergy or hypersensitivity to zonisamide or sulfonamides? - Not relevant.\n* Does s\/he have clinically significant laboratory abnormalities that would interfere with the conduct or interpretation of the study or jeopardize his\/her safety? - Not relevant.\n* Does s\/he have significant history or clinical evidence of auto-immune, cardiovascular, gastrointestinal, hematological, hematopoietic, hepatic, neurological, ongoing infection, pancreatic, or renal diseases that would interfere with the conduct or interpretation of the study or jeopardize his\/her safety? - Yes, the patient has Parkinson's disease.\n* Does s\/he have serious psychological illness? - Not relevant.\n* Does s\/he have significant history (within the past year) or clinical evidence of alcohol or drug abuse? - Not relevant.\n* Does s\/he have a positive urine drug screen, or a positive HIV-1, or hepatitis B or C screen, or a positive pregnancy test? - Not relevant.\n* Has s\/he consumed grapefruit or grapefruit juice during the 7-day period preceding study initiation? - Not relevant.\n* Is s\/he unable to refrain from the use of alcohol or xanthine-containing foods or beverages during periods beginning 48 hours prior to study drug administration and ending when the last blood sample has been taken? - Not relevant.\n* Has s\/he used any prescription drug during the 14-day period prior to study initiation, or any OTC drug during the 72-hour period preceding study initiation? - Not relevant.\n* Is s\/he unable to refrain from the use of all concomitant medications during the study? - Not relevant.\n* Has s\/he donated or lost blood, or participated in a clinical study which involved the withdrawal of a large volume of blood (480 mL or more), during the six week period preceding study initiation? - Not relevant.\n* Has s\/he donated plasma during the two week period preceding study initiation? - Not relevant.\n* Has s\/he received an investigational drug during the 30 day Period preceding study initiation? - Not relevant.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9854947752},{"ID":"14273_30-2021_NCT04482907","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.6651103457},{"ID":"6772_15-2021_NCT01945125","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have normal renal function?\nNo, the patient has chronic kidney disease (SCr 2.1 in [**3-17**]).\n\n#2. Does the patient have any of the exclusion criteria?\nYes, the patient has abnormal renal function.\n\nTherefore, the patient is excluded from the clinical trial.\n\nC: excluded","PROBA":0.8850788992},{"ID":"11756_17-2022_NCT02627339","TOPIC_YEAR":2022,"RESPONSE":"The patient is 67 years old, which is above the minimum age requirement of 10 years.\n\nThe patient has eye problems (slowly worsening vision in both eyes), which is a direct contradiction to the exclusion criterion of \"No eye diseases\". Therefore, the patient is not eligible for the clinical trial.\n\nC: excluded","PROBA":0.8522711901},{"ID":"27553_40-2022_NCT00835211","TOPIC_YEAR":2022,"RESPONSE":"The patient is a 23-year-old female who has prolonged oral bleeding after a tooth extraction.\n\nINCLUSION CRITERIA:\n\n* Healthy adult non-smoker (for at least 3 months) or light smoking (less than 10 cigarettes per day for at least 3 months)\n\nThe patient is a light smoker, so she meets this criterion.\n\n* Weighing at least 60 kg for males and 52 kg for females\n\nThe patient weighs at least 52 kg, so she meets this criterion.\n\n* Subjects who had a body mass index (BMI) less than 30\n\nThe patient's BMI is not provided, but based on her weight and height, she likely meets this criterion.\n\n* Medically healthy subjects with clinically normal laboratory profiles and ECGs\n\nThe patient has a normal platelet count and an abnormal ristocetin cofactor assay, as well as CB <= 0.30 IU\/mL and FVIII:C <= 0.40 IU\/mL, which suggests that she has a bleeding disorder. However, the study excludes subjects with any medical condition requiring regular treatment with prescription drugs, so the patient may still be eligible.\n\nEXCLUSION CRITERIA:\n\n* Female subjects who were pregnant or lactating\n\nThe patient is not pregnant or lactating, so she meets this criterion.\n\n* Subjects who had been on a special diet (for whatever reason) during the 28 days prior to the first dose and throughout the study\n\nThe patient is not on a special diet, so she meets this criterion.\n\n* Any clinically significant illness within 4 weeks prior to dosing\n\nThe patient has a history of prolonged oral bleeding, but this is not considered a clinically significant illness, so she meets this criterion.\n\n* Subjects with any medical condition requiring regular treatment with prescription drugs\n\nThe patient has a bleeding disorder, but this is not considered a medical condition requiring regular treatment with prescription drugs, so she meets this criterion.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.964521173},{"ID":"35758_75-2021_NCT04222088","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man with Parkinson's disease.\n\nParkinson's disease is not listed as an exclusion criterion.\n\nThe patient is not pregnant or breastfeeding, and there is no mention of any other underlying chronic or severe diseases.\n\nThe patient is not taking any regular medication that may interfere with the antimalarial pharmacokinetics.\n\nTherefore, based on the information provided, the patient would likely be eligible for the clinical trial.\n\nC: eligible","PROBA":0.8900304215},{"ID":"30870_65-2021_NCT03605979","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 25-year-old man with type 1 diabetes...\n\nYes, the patient meets the inclusion criteria of being >18 years old and having type 1 diabetes.\n\n...confirmed with molecular analysis 7 years ago...\n\nYes, the patient has a confirmed diagnosis of type 1 diabetes.\n\n...and is being treated with ACE inhibitors and Beta blockers...\n\nNo, the patient is not being treated with insulin pump therapy, which is a requirement for the clinical trial.\n\n...and had hypoglycemia unawareness...\n\nYes, the patient has hypoglycemia unawareness, which is a requirement for the clinical trial.\n\nTherefore, the patient is eligible for the clinical trial.\n\nA: eligible","PROBA":0.918577311},{"ID":"35323_75-2021_NCT00282152","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man with Parkinson's disease, which meets the INCLUSION CRITERIA of the clinical trial.\n\nThe patient has a clinical diagnosis of probable idiopathic Parkinson's disease, which is consistent with the INCLUSION CRITERIA.\n\nThe patient has demonstrated a response to dopaminergic therapy, as evidenced by the Hoehn-Yahr stage I, which meets the INCLUSION CRITERIA.\n\nThe patient is within the age range of 50-75 years old, which is an INCLUSION CRITERIA.\n\nThere are no EXCLUSION CRITERIA that are met by the patient.\n\nTherefore, the patient is eligible for the clinical trial. The answer is A: eligible.","PROBA":0.9066781201}]
